Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • PharmaTutor
    15 May 2011

    European Union BAN ON AYUSH DRUGS

    India has, so far, failed to get any assurance from the European Union to reconsider its ban on Indian herbal medicines even though the issue was raised at the EU through the official channel several times.

    The ban has come into effect from May 1, 2011, following a new EU regulatory procedure that was approved seven years back.

  • 15 May 2011
    AICTE SPONSORED TWO WEEKS STAFF DEVELOPMENT PROGRAMME ON RECENT ADVANCES IN DRUG DELIVERY & TECHNOLOGY - No Charge for ALL

    ABOUT GANPAT UNIVERSITY

  • 12 February 2011
    Novartis drug Afinitor extends progression-free survival in patients with advanced pancreatic neuroendocrine tumors

    The New England Journal of Medicine (NEJM) published a study that shows Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival (PFS), or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET)[1].

  • 12 February 2011
    Anesthesiologists Ask FDA to Okay Importation of Sodium Thiopental

    The American Society of Anesthesiologists (ASA) has asked the US Food and Drug Administration (FDA), for the sake of patient safety, to work with foreign governments to allow for the importation of sodium thiopental (Pentothal, Hospira) because domestic production of the controversial agent ceased in 2009.

  • 12 February 2011
    FDA Adds 13 Drugs to Watch List

    The US Food and Drug Administration (FDA) has released its latest list of drugs to monitor based on potential signs of serious risks or new safety information identified in the agency's Adverse Event Reporting System (AERS).

    The quarterly watch list consists of 13 medications that treat a wide range of conditions, including cough, angina, diabetes, cancer, and bipolar disorder.

  • 12 February 2011
    Researchers from UTHealth & Athersys present data illustrating potential benefits of MultiStem for treating stroke

    Medical researchers from The University of Texas Health Science Centre at Houston (UTHealth) presented new research results at the American Heart Association International Stroke Conference that demonstrated how MultiStem, a novel stem cell therapy being developed by Athersys, Inc. provided multiple benefits when administered in preclinical models of ischemic stroke.

  • 8 January 2011
    Stem Cell Defect Might Help Spur Common Baldness

    Common baldness could have its roots in a newly identified stem cell defect, a finding that could potentially lead to new hair-loss treatments down the road, a new study reveals. Researchers say they discovered that a cellular malfunction short-circuits the process by which hair follicle stem cells turn into hair-producing progenitor cells.

  • 8 January 2011
    Ecron Acunova CRO and Chulalongkorn University’s arm form Joint venture for clinical research

    Ecron Acunova (EA), a leading CRO with presence in Europe and Asia announced a joint venture with Jamjuree Innovations Co. Ltd., (JJI) Thailand. JJI is a 100% subsidiary of Chulalongkorn University Intellectual Property Foundation and enjoys strong ties with the University’s Faculty of Medicine, including Clinical Research Center (Chula CRC). The joint venture CRO is based in Bangkok and will conduct clinical research in key South East Asian countries under the name Ecron Acunova Company Ltd (EACL). Dr.

  • 8 January 2011
    Cell Biosciences Launches New Platform for Multiplex Western Blot Detection

    Cell Biosciences, Inc., a provider of innovative protein analysis tools to life science researchers, today announced the launch of the latest addition to their premier line of next-generation imaging products, the FluorChem® M MultiFluor system. This new platform combines highly-sensitive quantitative detection of multicolor fluorescent Western blots with key ease-of-use features aimed at simplifying the laboratory imaging process.

  • 18 December 2010
    New pharma policy on the anvil in India

    The New National Pharmaceutical Policy would soon be placed for consent before the Cabinet Ministers said Mr M K Azhagiri, Indian Minister of Chemicals & Fertilizers, at the conference on “Intellectual Property Rights: Challenges and Way Forward for the Pharmaceutical Industry”, organized by Confederation of Indian Industry (CII) held in Chennai (India) on December 15, 2010.

Subscribe to Pharma News